Frontiers in Pharmacology

Edit Your Profile

Frontiers in Pharmacology Journal

publication venue for

NOX4 Mediates Epithelial Cell Death in Hyperoxic Acute Lung Injury Through Mitochondrial Reactive Oxygen Species. 13. 2022
The Inhibition Effect of Linezolid With Reyanning Mixture on MRSA and its Biofilm is More Significant than That of Linezolid Alone. 12. 2022
Combination Therapy With Rapamycin and Low Dose Imatinib in Pulmonary Hypertension. 12. 2021
Andrographolide Sulfonate Is a Promising Treatment to Combat Methicillin-resistant Staphylococcus aureus and Its Biofilms. 12. 2021
The Antagonism of 5-HT6 Receptor Attenuates Current-Induced Spikes and Improves Long-Term Potentiation via the Regulation of M-Currents in a Pilocarpine-Induced Epilepsy Model. 11. 2020
Pulmonary Toxicity and the Pathophysiology of Electronic Cigarette, or Vaping Product, Use Associated Lung Injury. 10. 2020
Recalcitrant Issues and New Frontiers in Nano-Pharmacology. 10. 2019
Metformin Mitigates Fibrosis and Glucose Intolerance Induced by Doxorubicin in Subcutaneous Adipose Tissue. 9. 2018
Rumex dentatus Inhibits Cell Proliferation, Arrests Cell Cycle, and Induces Apoptosis in MDA-MB-231 Cells through Suppression of the NF-κB Pathway. 8. 2017
Serelaxin treatment reduces oxidative stress and increases aldehyde dehydrogenase-2 to attenuate nitrate tolerance. 8. 2017
Editorial: Hypertension: Novel Mechanisms of Nervous and Humoral Regulation 2022
Cannabidiol, a plant-derived compound, is an emerging strategy for treating cognitive impairments: comprehensive review of randomized trials 2024
Cannabidiol for neurodegenerative disorders: A comprehensive review 2022
Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes 2018

International Standard Serial Number (ISSN)

1663-9812

Electronic International Standard Serial Number (EISSN)

1663-9812